moatshark My

All holdings

Globus Medical

GMED

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$475k
Combined value at quarter end
Last quarter
0 bought
0 sold or trimmed
Price at Q2 ’26 end
$79.01
-8.3% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+3.6%Q3 ’13
+15.6%Q4 ’13
+31.8%Q1 ’14
-8.3%Q2 ’26
Q3 ’13: +3.6%; Q4 ’13: +15.6%; Q1 ’14: +31.8%; Q2 ’26: -8.3%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

0Q4 ’23
0Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
0Q3 ’25
0Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Q4 ’23: 0; Q1 ’24: 0; Q2 ’24: 0; Q3 ’24: 0; Q4 ’24: 0; Q1 ’25: 0; Q2 ’25: 0; Q3 ’25: 0; Q4 ’25: 0; Q1 ’26: 1; Q2 ’26: 1; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Globus Medical.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Globus Medical
Ruane, Cunniff & Goldfarb (Sequoia)0.0%$475k$475kUnchanged2 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Globus Medical
Bought or soldFiling
15 Sep 2026Tobin James RDirector▼ Sold30,000$74.58$2.2mForm 4
18 Aug 2026Zarrilli Stephen TDirector▼ Sold25,000$87.04$2.2mForm 4

About the company

Sector
Health care · Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Financial year ends
31 December
Shares outstanding
134m at 4 Aug 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$434m2013
$545m2015
$636m2017
$785m2019
$958m2021
$1.6bn2023
$2.9bn2025
2013: $434m; 2014: $474m; 2015: $545m; 2016: $564m; 2017: $636m; 2018: $713m; 2019: $785m; 2020: $789m; 2021: $958m; 2022: $1.0bn; 2023: $1.6bn; 2024: $2.5bn; 2025: $2.9bn
Globus Medical revenue and net income by year
YearRevenueNet income
2025$2.9bn$538m
2024$2.5bn$103m
2023$1.6bn$123m
2022$1.0bn$190m
2021$958m$149m
2020$789m$102m
2019$785m$155m
2018$713m$156m
2017$636m$107m
2016$564m$104m
2015$545m$113m
2014$474m$92.5m
2013$434m$68.6m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.